NCT00025779View on ClinicalTrials.gov

Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

November 30, 2003

Conditions
Attention Deficit Disorder With HyperactivityAutistic DisorderPervasive Development Disorders
Interventions
DRUG

methylphenidate

DRUG

guanfacine

Trial Locations (5)

21231

Kennedy Krieger Institute, Baltimore

43210

Ohio State University, Columbus

46202

Indiana University-Riley Hospital for Children, Indianapolis

90024

UCLA Neuropsychiatric Institute, Los Angeles

06520

Yale Child Study Center, New Haven

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00025779 - Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders | Biotech Hunter | Biotech Hunter